Chronic fatigue syndrome: studies on skeletal muscle. 1992

J M Grau, and J Casademont, and E Pedrol, and J Fernández-Solà, and F Cardellach, and N Barros, and A Urbano-Márquez
Department of Internal Medicine, Hospital Clínic i Provincial, Barcelona, Spain.

Chronic fatigue syndrome represents a poorly defined disease with protean clinical manifestations, the majority of them expressed as a muscle fatigue or as inability to maintain the expected muscle strength. In the present work we studied muscle function and muscle histopathology in 20 patients fulfilling the proposed criteria for chronic fatigue syndrome. Special interest is directed towards the immunoreactive expression of class I MHC molecules comparing some inflammatory and virus-related myopathies with muscles from chronic fatigue syndrome. Only minor morphological changes were detected in 9 out of 20 patients of the series. The nonspecific morphological changes in muscle tissue and the lack of class I MHC expression does not support the viral etiology of muscle fatigue in chronic fatigue syndrome. In contrast with the reported clinical improvement with high doses of essential fatty acids, our patients' clinical condition did not improve after three months of L-carnitine therapy.

UI MeSH Term Description Entries
D008297 Male Males
D008854 Microscopy, Electron Microscopy using an electron beam, instead of light, to visualize the sample, thereby allowing much greater magnification. The interactions of ELECTRONS with specimens are used to provide information about the fine structure of that specimen. In TRANSMISSION ELECTRON MICROSCOPY the reactions of the electrons that are transmitted through the specimen are imaged. In SCANNING ELECTRON MICROSCOPY an electron beam falls at a non-normal angle on the specimen and the image is derived from the reactions occurring above the plane of the specimen. Electron Microscopy
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009132 Muscles Contractile tissue that produces movement in animals. Muscle Tissue,Muscle,Muscle Tissues,Tissue, Muscle,Tissues, Muscle
D002331 Carnitine A constituent of STRIATED MUSCLE and LIVER. It is an amino acid derivative and an essential cofactor for fatty acid metabolism. Bicarnesine,L-Carnitine,Levocarnitine,Vitamin BT,L Carnitine
D003882 Dermatomyositis A subacute or chronic inflammatory disease of muscle and skin, marked by proximal muscle weakness and a characteristic skin rash. The illness occurs with approximately equal frequency in children and adults. The skin lesions usually take the form of a purplish rash (or less often an exfoliative dermatitis) involving the nose, cheeks, forehead, upper trunk, and arms. The disease is associated with a complement mediated intramuscular microangiopathy, leading to loss of capillaries, muscle ischemia, muscle-fiber necrosis, and perifascicular atrophy. The childhood form of this disease tends to evolve into a systemic vasculitis. Dermatomyositis may occur in association with malignant neoplasms. (From Adams et al., Principles of Neurology, 6th ed, pp1405-6) Polymyositis-Dermatomyositis,Dermatomyositis, Adult Type,Dermatomyositis, Childhood Type,Dermatopolymyositis,Juvenile Dermatomyositis,Juvenile Myositis,Adult Type Dermatomyositis,Childhood Type Dermatomyositis,Dermatomyositis, Juvenile,Myositis, Juvenile,Polymyositis Dermatomyositis
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

J M Grau, and J Casademont, and E Pedrol, and J Fernández-Solà, and F Cardellach, and N Barros, and A Urbano-Márquez
June 1987, Journal of neurology, neurosurgery, and psychiatry,
J M Grau, and J Casademont, and E Pedrol, and J Fernández-Solà, and F Cardellach, and N Barros, and A Urbano-Márquez
June 1997, Muscle & nerve,
J M Grau, and J Casademont, and E Pedrol, and J Fernández-Solà, and F Cardellach, and N Barros, and A Urbano-Márquez
June 1993, Journal of neurology, neurosurgery, and psychiatry,
J M Grau, and J Casademont, and E Pedrol, and J Fernández-Solà, and F Cardellach, and N Barros, and A Urbano-Márquez
January 2022, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
J M Grau, and J Casademont, and E Pedrol, and J Fernández-Solà, and F Cardellach, and N Barros, and A Urbano-Márquez
August 1964, Nagoya medical journal,
J M Grau, and J Casademont, and E Pedrol, and J Fernández-Solà, and F Cardellach, and N Barros, and A Urbano-Márquez
January 2006, Dynamic medicine : DM,
J M Grau, and J Casademont, and E Pedrol, and J Fernández-Solà, and F Cardellach, and N Barros, and A Urbano-Márquez
April 2021, Journal of translational medicine,
J M Grau, and J Casademont, and E Pedrol, and J Fernández-Solà, and F Cardellach, and N Barros, and A Urbano-Márquez
April 2012, Comprehensive Physiology,
J M Grau, and J Casademont, and E Pedrol, and J Fernández-Solà, and F Cardellach, and N Barros, and A Urbano-Márquez
November 1990, The Medical journal of Australia,
J M Grau, and J Casademont, and E Pedrol, and J Fernández-Solà, and F Cardellach, and N Barros, and A Urbano-Márquez
February 1991, The Medical journal of Australia,
Copied contents to your clipboard!